LOréal S.A. (OR) Fair Value & Analysis
Consumer Defensive · FR · Market cap €202B · ISIN FR0000120321
What is LOréal S.A. really worth?
A solid business, but trading 64% above our fair value of €234.27.
As of Aug 30, 2026, the fair value of LOréal S.A. is €234.27 per share against a price of €383.90, so the fair value sits 39% below the price. A model estimate blended from multiple valuation models, recalculated regularly.
Strengths
Risks
For context
Fair value as of: Aug 30, 2026
From 26 valuation models · updated 7 days ago
Share price −1.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (€302.10). The favourable scenario is already priced in.
- Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (€155.71 to €302.10) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.
How to read this chart
60‑month range €281.55 – €440.12 · fair‑value band €155.71 – €302.10 · the €383.90 price screens above the €234.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 30, 2026.
Analysis
LOréal S.A. (OR) currently trades at €383.90, while our model-based Fair Value estimate is €234.27, implying the stock looks roughly 63.9% overvalued today. The Quality Score stands at 69/100 (solid quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of €243.35 per share, and 0 of the 26 models we run sit above the €383.90 price. Bear case: the Asset-Based group reads lowest at €43.99, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, LOréal S.A. generated revenue of €44.1B at a net margin of 13.9%. Revenue grew 1.0% year over year. It earns a return on equity of 18.0%. Net debt stands at €2.1B. Fundamentals as of Aug 30, 2026
Our scenario range runs from €155.71 (bear case) to €302.10 (bull case); at €383.90, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 4% below its 52-week high and 16% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −36% fair-value upside, at −39%, OR screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly €2.90 per share, which is 1.2 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 26 models by family
Widest divergence: DCF Models (€243.35) versus Asset-Based (€43.99). Highest evidence: FCF DCF (79).
Notify me when OR reaches fair value
Put OR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty.
Full company description
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, Niely, L'Oréal Professionnel, Kérastase, Redken, Matrix, Pureology, Lancôme, Yves Saint Laurent Beauté, Armani Beauty, Kiehl's, Helena Rubinstein, Aesop, Biotherm, Valentino, Prada, Shu Uemura, IT Cosmetics, Mugler, Ralph Lauren, Urban Decay, Azzaro, Maison Margiela, Viktor&Rolf, Takami, La RochePosay, CeraVe, Vichy, SkinCeuticals, Skinbetter Science, and other brand names. The company sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and free-standing stores. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
LOréal S.A. reported revenue of €44.1B in FY2025 versus €32.3B in FY2021, a compound +8.1%/yr. Reported net income was €6.1B in FY2025, compounding +7.4%/yr from FY2021.
of which total revenue +6.7 % · buybacks/dilution +0.7 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
OR screens 64% overvalued. Compare with Unilever PLC →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- L'Oréal (ENXTPA:OR) Stock Looks Discounted On Cash Flow Yet Fair On Earnings
- Is L’Oréal (ENXTPA:OR) Leaning Too Heavily on Hero Products to Sustain Its Brand Power?
Peer Group
Household & Personal Products · 245 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
What the price implies (reverse DCF)
The inverse question: what free-cash-flow growth must LOréal S.A. deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.
The price demands roughly the growth the company recently delivered. Ranking of the largest stocks →
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: French Stocks
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| L'Oréal S.A LORL | C$24.76 | C$22.64 | −9% |
| Unilever PLC UNA | €55.92 | €40.47 | −28% |
| Colgate-Palmolive Company CL | $90.75 | $55.28 | −39% |
| 500696 500696 | ₹2,093 | ₹641.55 | −69% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | −61% |
| Kenvue Inc KVUE | $18.95 | $10.97 | −42% |
| Kimberly-Clark Corporation KMB | $109.55 | $79.71 | −27% |
| Henkel AG HEN3 | €76.42 | €85.95 | +12% |
| The Estée Lauder Companies Inc ESLA | €86.54 | €18.84 | −78% |
| Church & Dwight Co CHD | $101.26 | $65.12 | −36% |
Compare LOréal S.A. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is LOréal S.A. (OR) overvalued or undervalued?
What is the fair value of OR?
What is the quality score of OR?
What is the price target for LOréal S.A. (OR)?
What is the LOréal S.A. stock forecast for 2026?
What is the revenue of LOréal S.A. (OR)?
What is the net profit margin of OR?
Does LOréal S.A. pay a dividend?
What growth is priced into LOréal S.A. (OR)?
What discount rate (WACC) does the fair value of OR use?
Watch LOréal S.A. in the live analysis
One click puts LOréal S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.